Serum tRF5-23-GlyTCC-2 Functions as a Tumor Suppressor and Novel Biomarker for Colorectal Cancer
Serum tRF5-23-GlyTCC-2 exhibits high diagnostic accuracy, and its combination with CEA achieves superior sensitivity (84%), highlighting its potential as a powerful non-invasive biomarker to improve CRC detection and prognosis prediction.
Authors
- Yu‐Jen Wu (ORCID: https://orcid.org/0000-0002-8816-4725)
- Hui Dai (ORCID: https://orcid.org/0000-0001-7469-8745)
- Xinhui Lv (ORCID: https://orcid.org/0009-0002-6707-893X)
- Xudong Wang (ORCID: https://orcid.org/0000-0002-3522-3971)
- Jiyuan Yang
- Guihua Wang (ORCID: https://orcid.org/0000-0002-3624-6390)
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
Publication Details
- Journal
- Cancer Management and Research
- Published
- 2025-10-01
- DOI
- https://doi.org/10.2147/cmar.s540752
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00